Agios Pharmaceuticals (AGIO) Inventory (2018 - 2026)

Agios Pharmaceuticals (AGIO) has 8 years of Inventory data on file, last reported at $30.2 million in Q2 2026.

• Quarterly Inventory fell 2.26% year-over-year to $30.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $30.2 million (down 2.26% YoY) and the FY2025 annual result came in at $32.9 million, up 19.21% from the prior year.
• Inventory declined to $30.2 million in Q2 2026, from $35.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $35.1 million in Q1 2026 to a low of $2.5 million in Q1 2022.
• A 5-year average of $20.9 million and a median of $23.5 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory jumped 357.71% — and 2026, when it declined 2.26%.
• Tracing AGIO's Inventory over 5 years: stood at $8.5 million in 2022, then jumped by 124.63% to $19.1 million in 2023, then surged by 44.77% to $27.6 million in 2024, then grew by 19.21% to $32.9 million in 2025, then fell by 8.41% to $30.2 million in 2026.
• The last three Inventory figures came in at $30.2 million (Q2 2026), $35.1 million (Q1 2026), and $32.9 million (Q4 2025), per Business Quant data.